Biomechanics Responses to Power and Strength Combined Training

June 1, 2020 updated by: Karine Josibel Velasques Stoelben, Universidade Federal de Santa Maria

Lower Extremities Biomechanics Responses to Power and Strength Combined Training in Adults: a Randomized Clinical Trial

Anterior cruciate ligament (ACL) is the most frequently injured knee ligament during performance of recreational activities and sports. In the United States, the annual incidence is 68.6 per 100,000 people per year and in Brazil, the estimation of ACL reconstruction increases 64%. There are different biomechanical profiles of risk factors for an ACL injury variable, the ligament dominance, the quadriceps dominance, the trunk dominance, and the leg dominance. Thus, the purpose of this study is to investigate the biomechanics adaptations after power and strength combined training protocol in healthy individuals. A second aim is to determine the effect of the training on knee injury risk factors.

Study Overview

Status

Unknown

Conditions

Detailed Description

This is a parallel randomized clinical trial comparing the effect of combined training with power and strength exercises on lower extremity biomechanics in healthy individuals.

The sample size was calculated with G*Power software using the ANOVA: Repeated measures, within-between interaction, 90% power, alpha 0.05, and 30% drop-out. Data from the tuck jump test (knee flexion range) by Makaruk (2014) were considered for this calculation with effect size 0.46. Thus, a total of 32 individuals (16 per group) is required for this study. To ensure the proper simple size, after collecting the first five participants per group, the sample size will be checked again.

The participants will be randomized in experimental and no intervention groups inside each risk profile group. Randomization ratio will be 1:1 and interventions will last 10 weeks, with two weekly sessions for the exercise arms.

The outcomes will include functional clinical tests, kinematic and kinetic variables during landing tasks, and strength of knee and hip muscles.

The data analysis will be performed by intention to treat and per protocol. Generalized estimating equations will be used to identify interaction effects of groups and time followed by Bonferroni post-hoc. When effect are found, effect size will be estimated. Missing data will be estimate by statistical analysis.

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Sul
      • Uruguaiana, Rio Grande Do Sul, Brazil, 97502-772
        • Karine Josibel Velasques Stoelben

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male sex;
  • Age between 18 and 30 years old;
  • Who practice physical activity (except: strength and jump training) between 80 and 150 minute per week;
  • No previous muscle lower extremity injury at least 6 months prior to recruitment;
  • No previous ligament and tendon lower extremity injury or surgery;
  • No auditory, vestibular, visual or musculoskeletal injuries or disease that impairment the execution of assessments or training protocol;
  • No hypertension, cardiovascular or respiratory disease.

Exclusion Criteria:

  • Body mass index greater than 35 kg/m².

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Individuals randomized to experimental group.

The training will be compose by power and strength exercises and divided in two days. One day with the exercises: vertical jumps, box jumps, sit-ups, back-extension and guided squat. The second with half squat jumps, high straight jumps, bounding jumps, drop jumps and sprint. Both days will be started with warm up on treadmill running lasting 5 minutes at 6.5-7.5 km/h.

The training protocol includes 20 sessions with 2 sessions per week during 10 weeks (2 weeks to adaptation and others 8 to training with progression of load after 4 weeks).

No Intervention: No Intervention Control
Individuals without quadriceps dominance randomized to no intervention group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline peak sagittal plane angle of ankle, knee and hip from both legs
Time Frame: Baseline and up to 10 weeks
Peak angle of sagittal plane during landing task
Baseline and up to 10 weeks
Change from baseline value of sagittal plane angles for ankle, knee, hip, pelvis from both legs, and trunk
Time Frame: Baseline and up to 10 weeks
Value at initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline value of frontal plane angles for ankle, knee, hip, pelvis from both legs, and trunk
Time Frame: Baseline and up to 10 weeks
Value at initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline value of transverse plane angles for hip, pelvis from both legs, and trunk
Time Frame: Baseline and up to 10 weeks
Value at initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline peak frontal plane angle of knee and hip from both legs
Time Frame: Baseline and up to 10 weeks
Peak angle of frontal plane during landing task
Baseline and up to 10 weeks
Change from baseline range of knee frontal plane angle from both legs
Time Frame: Baseline and up to 10 weeks
Range of frontal plane angle between initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline range of knee sagittal plane angle from both legs
Time Frame: Baseline and up to 10 weeks
Range of sagittal plane angle between initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline value of sagittal plane joint moment knee and hip from both legs
Time Frame: Baseline and up to 10 weeks
Value at initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline value of frontal plane joint moment knee and hip from both legs
Time Frame: Baseline and up to 10 weeks
Value at initial contact instant and maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline peak of knee frontal plane joint moment from both legs
Time Frame: Baseline and up to 10 weeks
Peak of joint moment during landing task
Baseline and up to 10 weeks
Change from baseline value of ground reaction force vertical component from both legs
Time Frame: Baseline and up to 10 weeks
Value at maximal knee flexion instant of landing task
Baseline and up to 10 weeks
Change from baseline value of loading rate from both legs
Time Frame: Baseline and up to 10 weeks
Value calculated by relation between peak of ground reaction force vertical component and time to peak from initial contact during landing task
Baseline and up to 10 weeks
Change from baseline peak of ground reaction force vertical component from both legs
Time Frame: Baseline and up to 10 weeks
Peak of ground reaction force during landing task
Baseline and up to 10 weeks
Change from baseline value of muscle maximal isometric strength for knee extensors and flexors, and hip aductors and abductors from both legs
Time Frame: Baseline and up to 10 weeks
Value of maximal isometric strength
Baseline and up to 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline pennation angle of muscle fibers of knee extensors and flexors from both legs
Time Frame: Baseline and up to 10 weeks
The angle between the longitudinal axis of the entire muscle and its fibers.
Baseline and up to 10 weeks
Change from baseline muscle fascicle length of knee extensors and flexors from both legs
Time Frame: Baseline and up to 10 weeks
The distance between the intersection composed of the superficial aponeurosis and fascicle and the intersection composed of the deep aponeurosis and the fascicle
Baseline and up to 10 weeks
Change from baseline muscle thickness of knee extensors and flexors from both legs
Time Frame: Baseline and up to 10 weeks
Estimation of muscle cross-sectional area
Baseline and up to 10 weeks
Change from baseline power value of ankle, knee and hip joints from both legs
Time Frame: Baseline and up to 10 weeks
Relation of work and velocity during landing task
Baseline and up to 10 weeks
Change from baseline dynamic strength of lower extremities muscles
Time Frame: Baseline and up to 10 weeks
The force developed to perform one maximal repetition to perform leg press and squat tasks
Baseline and up to 10 weeks
Change from baseline maximal dorsiflexion amplitude of ankle joint from both legs
Time Frame: Baseline and up to 10 weeks
Maximal dorsiflexion amplitude obtained during lunge test
Baseline and up to 10 weeks
Change from baseline dynamic balance of lower extremities from both legs
Time Frame: Baseline and up to 10 weeks
Dynamic balance is assessed according the displacement obtained during Star Excursion Balance Test
Baseline and up to 10 weeks
Change from baseline dynamic balance index of asymmetry between legs
Time Frame: Baseline and up to 10 weeks
Dynamic balance is assessed according the displacement obtained during Star Excursion Balance Test. The asymmetry index is calculated by relation between preferred and non preferred legs.
Baseline and up to 10 weeks
Change from baseline quality of dynamic movement of lower extremities from both legs
Time Frame: Baseline and up to 10 weeks
Quality of movement is assessed according the escore obtained during Lateral Step Down test performance
Baseline and up to 10 weeks
Change from baseline asymmetry index of quality of dynamic movement between legs
Time Frame: Baseline and up to 10 weeks
Quality of movement is assessed according the escore obtained during Lateral Step Down test performance. The asymmetry index is calculated by relation between preferred and non preferred legs.
Baseline and up to 10 weeks
Change from baseline functional physical performance of lower extremities from both legs
Time Frame: Baseline and up to 10 weeks
Assessed according the maximal distance obtained during hop tests performance (single, triple and crossover)
Baseline and up to 10 weeks
Change from baseline asymmetry index of functional physical performance between legs
Time Frame: Baseline and up to 10 weeks
Assessed according the maximal distance obtained during hop tests performance (single, triple and crossover). The asymmetry index is calculated by relation between preferred and non preferred legs.
Baseline and up to 10 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Training load of each training session
Time Frame: At the end of each training session throughout 10 weeks
Product between rate of perceived exertion and session duration training
At the end of each training session throughout 10 weeks
Muscle Soreness after each training session
Time Frame: 24 and 48 hours after each training session throughout 10 weeks
Value from visual analog scale (score between 0 to 10 points) representative to discomfort or pain after training sessions. Higher values represent worst discomfor/pain
24 and 48 hours after each training session throughout 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Felipe P Carpes, PhD, Federal University of Pampa
  • Principal Investigator: Karine JV Stoelben, Ms, Federal University of Pampa
  • Study Chair: Eliane C Guadagnin, PhD, Federal University of Pampa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2019

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

September 4, 2019

First Submitted That Met QC Criteria

October 22, 2019

First Posted (Actual)

October 25, 2019

Study Record Updates

Last Update Posted (Actual)

June 4, 2020

Last Update Submitted That Met QC Criteria

June 1, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 96793518.3.0000.5323

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The investigators intend to publish the results in an open-access journal, indexed at the Directory of Open Access Journals, with the copyrights transferred to the authors. Details regarding the study's design and statistical plan can be obtained consulting the trial's protocol. Data on other outcomes could be requested contacting the PI.

IPD Sharing Time Frame

The individual participant dataset will become available at a public repository up to six months after the first study publication

IPD Sharing Access Criteria

A simple registration will grant access to study datasets. The website for these files is not defined at the time of registration.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Combined training with power and strength exercises

3
Subscribe